At this juncture, the promising proteomics market is too small to be a surefire investment.
SkyWater Technology bills itself as the only U.S. chip manufacturing pure-play, but it's still in start-up mode.
Cathie Wood fave Quantum-Si stock could be as much as six years away from profitability.
Institutional buying, led by Cathie Wood's ARK Genomic Revolution ETF, spurred other investors to buy the stock.
This small chip stock doesn't generate revenue yet, but that might change soon.
Wood's company recently invested millions into a semiconductor company that might not be on your radar.
Despite falling in today's trading, Quantum-Si stock still gained 17.6% this week.
Institutional buying helped drive up the medical equipment maker's stock.
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jeff Keyes as its new Chief Financial Officer,...
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointments of Katherine Atkinson as Senior Vice President...